MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in A Moroccan adult population: A case-control study and meta-analysis

Schiffer, 2003, Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia, New Engl J Med, 349, 727, 10.1056/NEJMp030076 Smith, 2011, Benzene, the exposome and future investigations of leukemia etiology, ChemBiol Interact, 192, 155, 10.1016/j.cbi.2011.02.010 Poynter, 2017, Chemical exposure and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study, Int J Cancer, 140, 23, 10.1002/ijc.30420 Rothman, 2001, The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens, BiochimBiophys Acta, 1471, C1 Marzolini, 2004, Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance, Clin Pharmacol Ther, 75, 13, 10.1016/j.clpt.2003.09.012 Thiebaut, 1987, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues, Proc Natl Acad Sci U S A, 84, 7735, 10.1073/pnas.84.21.7735 Jonge-Peeters, 2007, ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance, Crit Rev Oncol Hematol, 62, 214, 10.1016/j.critrevonc.2007.02.003 Annese, 2006, Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis, World J Gastroenterol, 12, 3636, 10.3748/wjg.v12.i23.3636 Li, 2006, MDR1 gene polymorphisms and clinical relevance, Yi Chuan Xue Bao, 33, 93 Horinouchi, 2002, Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin, Pharm Res, 19, 1581, 10.1023/A:1020433422259 Sheng, 2012, MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case–control studies, Mol Biol Rep, 39, 7237, 10.1007/s11033-012-1554-7 Kim, 2001, Identification of functionally variant MDR1 alleles among European americans and African Americans, Clin Pharmacol Ther, 70, 189, 10.1067/mcp.2001.117412 Wasilewsk, 2007, MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children, Pediatr Nephrol, 22, 44, 10.1007/s00467-006-0275-3 Kassogue, 2014, Single nucleotide polymorphisms ofmultidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia, Tumor Biol, 35, 10969, 10.1007/s13277-014-2400-4 Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215 Feng, 2016, Role of ABCB1 C1236T, G2677T, and C3435T genetic polymorphisms in the development of acute leukemia in a Chinese population, Genet Mol Res, 15, 10.4238/gmr.15038546 Kimchi-Sarfaty, 2007, A “silent’’ polymorphismin the MDR1 gene changes substrate specificity, Science, 315, 525, 10.1126/science.1135308 Yan, 2014, Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis, Tumour Biol, 35, 2191, 10.1007/s13277-013-1291-0 Wang, 2013, The association between polymorphisms in the MDR1 gene and risk of cancer: a systematic review and pooled analysis of 52 case–control studies, Cancer Cell Int, 13 Ait Boujmia, 2017, Association of glutathione S-transferase genes (M1 and T1) with the risk of acute myeloid leukemia in a Moroccan population, Middle East J Cancer, 8, 7 El-Tokhy, 2014, XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients, Hematology, 19, 397, 10.1179/1607845413Y.0000000144 Kim, 2012, Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients, Eur. J Cancer, 49, 403, 10.1016/j.ejca.2012.07.022 Zendehdel, 2009, Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers, Cancer Cause Control, 20, 2031, 10.1007/s10552-009-9399-7 Illmer, 2002, MDR gene polymorphisms affect therapy outcome in acute myeloid leukemia patients, Cancer Res, 62, 4955 Jamroziak, 2006, No influence of 3435C&T ABCB1(MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells, Ther Drug Monit, 28, 707, 10.1097/01.ftd.0000245770.75097.3f Leith, 1999, Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia, A Southwest Oncology Group Study. Blood., 94, 1086 Rao, 2010, Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India, Asian Pac J Cancer Prev: APJCP, 11, 1063 AL-Faisal, 2014, Effect of MDR1 gene expression related with C1236T polymorphism in Iraqi acute myeloid leukemia patients, Iraqi J Biotechnol, 13, 253 Gréen, 2012, Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype, Pharmacogenomics, 12, 111, 10.1038/tpj.2010.79 Li, 2016, Association of ABCB1 C3435T and C1236T gene polymorphisms with the susceptibility to acute myeloid leukemia in a Chinese population, Int J ClinExpPathol, 9, 8464 Zhang, 2013, Association between the MDR1 gene variant C3435T and risk of leukemia: a meta-analysis, Eur J Cancer Care (Engl), 22, 617, 10.1111/ecc.12067 Qian, 2012, Variant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case-control studies, Leuk Lymphoma., 53, 1183, 10.3109/10428194.2011.641179